| ID | Sequence | Length | GC content |
|---|---|---|---|
| AAGGCCCAGACGGCUCUCAGAUCCGGGGGCUGCGGAUAAAUCCCCGUAG… | 785 nt | 0.5274 | |
| AAGGCCCAGACGGCUCUCAGAUCCGGGGGCUGCGGAUAAAUCCCCGUAG… | 4207 nt | 0.5132 | |
| AAGGCCCAGACGGCUCUCAGAUCCGGGGGCUGCGGAUAAAUCCCCGUAG… | 878 nt | 0.5194 |
Predicted to enable zinc ion binding activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process and protein targeting to ER. Predicted to act upstream of or within cellular response to arsenic-containing substance and positive regulation of proteasomal ubiquitin-dependent protein catabolic process. Predicted to be located in nucleus. Predicted to be part of proteasome complex. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
A study in humans demonstrated that the ZFAND2A was identified as one of 16 overlapping blood transcriptomic biomarkers for early prediction of multiple organ failure following blunt trauma, with the biomarker panel achieving high predictive accuracy (e.g., AUROC up to 0.907 in test sets) [Duran et al. DOI:10.1186/s13613-024-01364-5].